Biomarker
Immune protein level, combined with BNP, may improve prognostic value of HF risk models
Addition of soluble urokinase-type plasminogen activator receptor levels to models including B-type natriuretic peptide may improve their prognostic value for patients with HF, researchers reported.
Biomarkers predict effectiveness of dupilumab treatment for moderate to severe asthma
Elevated baseline levels of type 2 biomarkers predicted improved lung function and reduced exacerbation rates with dupilumab among patients with asthma, according to a study in The Journal of Allergy and Clinical Immunology: In Practice.
Researchers identify most studied biomarkers in the setting of CKD
Investigators identified tumor necrosis factor receptor 1 as the most frequently studied plasma biomarker in the setting of chronic kidney disease progression.
Biomarker algorithm may not accurately identify patients with eosinophilic asthma
A group of biomarkers proposed in previous research insufficiently diagnosed eosinophilic phenotypes among patients with asthma, according to a study published in Clinical and Translational Allergy.
Q&A: Biomarker testing opens doors for personalized treatment options in lung cancer
In an interview with Healio, Julia Rotow, MD, spoke about the importance of biomarker testing, the best methods to identify these biomarkers and new advances in personalized treatment options for patients
Cerveau, Alnylam partner on tau biomarker imaging agent for PET scans
Cerveau Technologies Inc. announced a partnership with Alnylam Pharmaceuticals, which will use Cerveau’s investigational imaging agent in positron emission tomography scans to evaluate neurofibrillary tangles in the brain.
Day-of-injury biomarkers reliable predictors of mortality, unfavorable outcomes after TBI
Biomarkers collected on the day of traumatic brain injury had significant prognostic value for death and unfavorable outcome but not for incomplete recovery at 6 months, according to a study published in The Lancet Neurology.
Noninvasive biomarker platform for fluid assessment in HF cleared
Bodyport announced its noninvasive biomarker platform, made in the form of a scale, received FDA clearance for measurement of fluid status and heart function in patients requiring fluid management.
Tape strips capture atopic dermatitis biomarkers in children
inimally invasive tape strips capture immune-related and barrier-related markers of atopic dermatitis in lesional and non-lesional skin across pediatric age groups, according to a letter published in Allergy.
CSF biomarkers support AD diagnosis in nearly 90% of clinical cases
SAN DIEGO — Cerebrospinal fluid biomarkers supported the clinical diagnosis of Alzheimer’s disease in a small cohort of patients, per a poster presentation at the Alzheimer’s Association International Conference.